Education
About Us
Working with TipRanks
Follow Us
AstraZeneca PLC (SE:AZN)
:AZN
Total Valuation
AstraZeneca has a market cap or net worth of £2.33T. The enterprise value is kr176.61B.
Market Cap£2.33T
Enterprise Valuekr176.61B
Share Statistics
AstraZeneca has 1,550,682,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,550,682,600
Owned by Insiders0.03%
Owned by Institutions0.01%
Financial Efficiency
AstraZeneca’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 12.90%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)12.90%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee561.44K
Profits Per Employee92.16K
Employee Count94,300
Asset Turnover0.51
Inventory Turnover2.50
Valuation Ratios
The current PE Ratio of AstraZeneca is 27.1. AstraZeneca’s PEG ratio is ―.
PE Ratio27.1
PS Ratio―
PB Ratio―
Price to Fair Value4.98
Price to FCF―
Price to Operating Cash Flow18.00
PEG Ratio―
Income Statement
In the last 12 months, AstraZeneca had revenue of 52.94B and earned 6.89B in profits. Earnings per share was 4.44.
Revenue52.94B
Gross Profit39.70B
Operating Income12.52B
Pretax Income8.51B
Net Income6.89B
EBITDA14.86B
Earnings Per Share (EPS)4.44
Cash Flow
In the last 12 months, operating cash flow was 13.39B and capital expenditures -4.67B, giving a free cash flow of 8.72B billion.
Operating Cash Flow13.39B
Free Cash Flow8.72B
Free Cash Flow per Share5.63
Dividends & Yields
AstraZeneca pays an annual dividend of kr9.957, resulting in a dividend yield of 2.1%
Dividend Per Sharekr9.957
Dividend Yield2.1%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.44
52-Week Price Change-12.57%
50-Day Moving Average1.38K
200-Day Moving Average1.42K
Relative Strength Index (RSI)68.67
Average Volume (3m)311.46K
Important Dates
AstraZeneca upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateJul 29, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend DateAug 07, 2025
Financial Position
AstraZeneca as a current ratio of 0.93, with Debt / Equity ratio of 73.43%
Current Ratio0.93
Quick Ratio0.74
Debt to Market Cap0.14
Net Debt to EBITDA1.66
Interest Coverage Ratio9.19
Taxes
In the past 12 months, AstraZeneca has paid 1.62B in taxes.
Income Tax1.62B
Effective Tax Rate0.19
Enterprise Valuation
AstraZeneca EV to EBITDA ratio is 15.32, with an EV/FCF ratio of 31.29.
EV to Sales4.30
EV to EBITDA15.32
EV to Free Cash Flow31.29
EV to Operating Cash Flow19.19
Balance Sheet
AstraZeneca has £7.11B in cash and marketable securities with £32.84B in debt, giving a net cash position of £25.73B billion.
Cash & Marketable Securities£7.11B
Total Debt£32.84B
Net Cash£25.73B
Net Cash Per Share£16.59
Tangible Book Value Per Share-£11.18
Margins
Gross margin is 72.60%, with operating margin of 23.65%, and net profit margin of 13.01%.
Gross Margin72.60%
Operating Margin23.65%
Pretax Margin16.07%
Net Profit Margin13.01%
EBITDA Margin28.06%
EBIT Margin18.70%
Analyst Forecast
The average price target for AstraZeneca is £1,745.98, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target£1,745.98
Price Target Upside16.40% Upside
Analyst ConsensusStrong Buy
Analyst Count13
Revenue Growth Forecast―
EPS Growth Forecast―